We describe a case of a female with simple virilizing congenital adrenal hyperplasia (CAH) reared as a male diagnosed at the late age of 64.
Further investigations and management
Subsequent blood tests confirmed grossly elevated 17α-OH-progesterone > 750 nmol/L (Normal male: 0.9-6.6nmol/L), progesterone 342 nmol/L (Normal male: 0.66-4.89nmol/L), DHEA-S 5050 ng/ml (Normal male: 800-5600) and androstenedione 2945 ng/dL (Normal male: 50-220), in line with 21-hydroxylase deficiency. Testosterone level was 33 nmol/L and was within normal range for an adult male (Normal male: 10-35nmol/L). Adrenocorticotropic hormone (ACTH), cortisol and corticosterone metabolites were normal. Serum sodium and potassium levels were normal. Prostate specific antigen was 3.6ng/ml (Normal male: <4ng/ml). Urine catecholamines were not elevated, excluding phaeochromocytoma. Karyotyping returned 46XX.
Uroflometry showed only mild lower urinary tract obstruction and he was taken off Terazosin. His urinary symptoms were attributed to recurrent urinary tract infections which were treated accordingly.
Although the high percentage contrast washout of the adrenal mass was suggestive of adenoma, its large size and presence of heterogeneous component were atypical. Laparoscopic right adrenalectomy, hysterectomy and bilateral salpingooophorectomy were performed with perioperative hydrocortisone supplementation. Due to technical reasons, the right adrenal gland was removed in a piecemeal fashion. Histopathology showed adrenocortical hyperplasia but was unable to differentiate between a hyperplastic nodule and an adenoma due to the piecemeal nature of the specimen. No malignancy was detected. No evidence of testicular tissue was detected in the ovaries. In view of old age and the patient being well all along except for his urinary symptoms, regular corticosteroid replacement was not given. He remained well currently at one year post-operation.
Etiology and demographics
Congenital adrenal hyperplasia can be divided into the more severe classical and the milder non-classical or late-onset types. The incidence of classical CAH based on neonatal screening programs is 1 in 15000-16000 live births worldwide with significant geographical and ethnical variations [1, 2]. Non-classical or late-onset CAH has a much higher incidence of 1:1000 worldwide [1] . The disease follows an autosomal recessive inheritance. It is caused by an enzymatic deficiency in the biosynthesis of cortisol and aldosterone. Although the disease can be due to deficiency of five different enzymes, over 90% of cases are due to 21-hydroxylase deficiency [3] . This results in decreased levels of cortisol and aldosterone and shunting of intermediate metabolites towards production of excess androgens. Reduced negative feedback from cortisol leads to continued adrenocorticotropic hormone (ACTH) hyperstimulation, causing adrenal hyperplasia and androgen excess.
Clinical presentation
Depending on the severity of the enzymatic defect, the disease could range from being totally subclinical to causing death shortly after or even before birth.
Classical CAH comprises the salt wasting form and the simple virilizing form. The salt wasting form is the most severe form of the disease and accounts for 75% of classical CAH cases [1] . In this form, both aldosterone and cortisol are deficient and marked androgen excess is present. Apart from signs of androgen excess which could be present at birth, most evidently as ambiguous genitalia in girls, affected infants present within weeks after birth with failure to thrive, recurrent vomiting, dehydration and shock in a salt wasting crisis. This is typically fatal without treatment.
The current patient had a partial 21-hydroxylase deficiency that was mild enough not to have caused salt wasting but severe enough to have resulted in masculinized external genitalia. This falls into the category of simple virilizing form of CAH. In this form of the disease, cortisol is not synthesized efficiently, but aldosterone secretion is adequate and sodium balance is maintained. Patients with this form of the disease are mainly affected by hypocortisolism and androgen excess. The former puts them at risk of adrenal crisis while the latter manifests as ambiguous genitalia and menstrual disturbances in girls and hirsutism, pseudoprecocious puberty, advanced skeletal maturity with resultant short final height, acne, alopecia, infertility, etc., in both sexes. As ambiguous genitalia due to 21-hydroxylase deficiency affects only females while males present with penile enlargement which is clinically more subtle, diagnosis in males is often delayed [3] . Classical CAH is by far the most common cause of ambiguous genitalia worldwide.
Non-classical or late onset CAH is the milder form of the disease. The clinical presentation is of androgen excess which is generally milder than in the classical forms. Patients typically present in late childhood or early adulthood although some may remain asymptomatic for life [4] . Hirsutism is the most common symptom [4] .
As CAH was only better understood by the medical community in the later decades of the 20th century, it was no surprise that our patient was not diagnosed at birth and was wrongly assigned male gender.
Radiological findings in CAH
As a metabolic disease, CAH has manifestations in multiple organ systems. The following entities are those which concern radiologists.
The adrenals
Studies on imaging appearance of the adrenal glands in CAH are scarce and mostly comprise small series and case reports.
The potential use of sonography of the adrenal glands as a rapid screening tool for CAH in neonates and infants has been studied. The size of adrenal glands in CAH neonates has been shown to be substantially larger than in normal neonates although significant overlap exists [5] [6] [7] [8] . Adrenal length >20mm and width >4mm in the newborn could suggest the diagnosis [8] . Disease severity correlates with adrenal gland size [7, 8] . Later studies showed that "cerebriform" or coiled appearance of the adrenal glands, which reflects the enlarged elongated glands crammed within a confined space is a good discriminator between CAH and normal subjects [9, 10] . In neonates or infants suspected to have classical CAH due to ambiguous genitalia or salt wasting, sonography of the adrenals achieved >90% sensitivity and 100% specificity in diagnosing CAH [9, 10] . With adequate treatment, the size and appearance of the glands typically return to normal in a few months [9, 10] . Adrenal mass is not frequently reported in neonates with CAH, possibly due to the relatively short duration of ACTH hyperstimulation.
Antenatal sonographic visualization of enlarged or "cerebriform" adrenal glands or ambiguous genitalia in fetuses affected by CAH have been reported, but cases are too few to establish its diagnostic reliability [11] [12] [13] [14] [15] [16] [17] [18] [19] .
In the older pediatric age group and in adults, the most frequently reported imaging abnormalities of the adrenal glands in CAH, treated or untreated, are bilateral enlargement and unilateral or bilateral adrenal mass(es) [20] [21] [22] [23] [24] [25] [26] [27] . Adrenal enlargement could be smooth or nodular. The term mass here incorporates nodules which are essentially smaller nodular masses. Jaresch et al. found 82% of CAH patients had adrenal mass on CT with incidence and size of the masses apparently positively correlated with the degree and duration of ACTH stimulation [23] . Reisch et al. showed that total adrenal gland volume on MRI correlated with hormonal control [26] . It was also shown in multiple studies that adequate treatment could lead to morphological normalization of the adrenal glands, with shrinkage or even resolution of some adrenal masses [25, [28] [29] [30] . Over-treatment resulting in hypoplastic appearance of the adrenals on imaging has been reported [21, 24] . These are in keeping with the widely held notion that the morphological changes of the adrenals in CAH are largely ACTH dependent thus reflecting disease severity and treatment adequacy. Whether adrenal imaging can be used to help titrate treatment however has yet to be explored.
In another study by Jaresch et al., 82% of homozygotes and 45% of heterozygotes for CAH had adrenal mass [22] . On the other hand, Baumgartner-Parzer et al. showed that 16% and 2% of subjects with adrenal incidentaloma found on CT were heterozygous and homozygous for classical CAH respectively [27] . Thus it seems adrenal tumors are very common in CAH but not vice versa. Nonetheless, the differential of CAH should be borne in mind when an adrenal tumor is encountered, particularly during workup for virilization for one may step into the diagnostic pitfall of solely attributing the hormonal disturbance to the tumor while the underlying problem which may be CAH instead may be completely overlooked [31] . To complicate matters more, functional adrenal tumors may coexist with and biochemically mask underlying CAH [32] [33] [34] .
A few cases of normal adrenal morphology on CT or MRI in untreated non-classical CAH in adults have been reported [23, 35] . However, to our knowledge, such finding has not been reported in untreated classical CAH in adults despite the sizable number of untreated adult classical CAH cases reported in the literature. Thus abnormal adrenal morphology on CT or MRI is probably a very sensitive marker for untreated classical CAH in adults. Adrenal mass or enlargement is however not specific for CAH.
Adrenocortical adenomas are well known to occur in CAH. Less well known is that adrenal myelolipoma is also associated with CAH [24, 36] . The imaging diagnosis of the latter is rather straightforward, requiring visualization of macroscopic fat. The only documented prevalence of myelolipomas in a heterogeneous group of CAH patients is 6% (4 in 62) [24] . The imaging and histopathological distinction between adenomas and hyperplastic macronodules is often not possible, as was the case in our patient. Fortunately, such a distinction is not of great clinical importance. The high prevalence of masses reported by Jaresch et al. and Reisch et al. of 82% and 73% respectively likely represented the combined prevalence of adenomas and hyperplastic macronodules [23, 26] . A low prevalence of 3% adenomas and 0% hyperplastic macronodule was reported by Nermoen et al. [24] . Such large discrepancy may reflect different hormonal control between the studied populations.
Studies on radiological characterization of adrenal masses in CAH are lacking, thus whether adrenocortical adenomas and myelolipomas occurring in CAH have different imaging characteristics from those generally described is unknown.
Only a few cases of adrenal carcinoma and one case of phaeochromocytoma occurring in CAH have been reported [24, 37, 38] . No definite association between these two entities and CAH has been established.
Urogenital tract anomalies
Pelvic sonography for identification of the uterus is routinely done for patients with ambiguous genitalia. Female infants with completely masculinized external genitalia may present at sonography as boys with bilateral cryptorchidism who require localization of the testes. Female pseudohermaphrodites due to CAH should always have a normal uterus. For those who need corrective urogenital surgery, further delineation of the internal portions of the urogenital tract with sonography or urogenitography might be needed preoperatively [39] . Nabhan et al. found 21% (14 out of 66) of girls with ambiguous genitalia due to CAH had upper urinary tract abnormalities which included vesicoureteric reflux, hydronephrosis and duplicated collecting system [40] . Thus sonography of the kidneys and micturating cystourethrography should probably be performed for all patients in this subgroup. The incidence of urinary tract abnormalities in boys with CAH is unknown.
Adrenal rest tumors
Chronically increased ACTH can lead to tumor formation in adrenal rests in the body, most commonly in the testes. In the largest cohort of patients with CAH due to 21-hydroxylase deficiency (n=244, 46% male), testicular adrenal rest tumor (TART) was found on sonography in 44% men (>18 years of age) and 33% boys (4-18 years of age; youngest patient with TART was 4.1 year-old) with classical CAH [41] . Reported cases of TART in CAH occurred almost exclusively in the classical form. Since TARTs are usually not palpable unless larger than 2cm, diagnosis relies heavily on imaging. Sonography and MRI are equally good in this regard [42] . The typical appearance on sonography is multiple nodular hypoechoic foci arising from the testicular hilar region, bilateral in 80%. Hyperechogenicities appear in the later stages due to fibrosis and fatty infiltration, which irreversibly impair spermatogenesis [42] . On MRI, TARTs are T1 isointense to slightly hyperintense and T2 hypointense to normal testicular tissue and diffusely enhance [43] . Malignant change in TART has not been documented thus recognition of this association is important to avoid unnecessary orchidectomy. Imaging differentiation of mass forming TARTs from other testicular tumors may be difficult. Presence of vessels crossing the lesion without deviation has been described as a feature of TART [43] . Other useful differentiating features include negative testicular tumor markers, increased cortisol on gonadal vein sampling and suppressibility by gluccocorticoid treatment [43] .
In contrast to TART in males, ovarian adrenal rest tumors (OART) in CAH are rare with occurrences limited to isolated case reports [44] [45] [46] [47] [48] . Limited radiological information in these reports suggests that they are solid echogenic masses.
Adrenal rest tumors in CAH have also been reported to have occurred at the renal hilar region and in the retroperitoneum with encasement of the aorta and renal arteries [49, 50] . Successful use of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in detecting adrenal rest tumors have been reported in two cases, one in the ovaries and the other in the para-ovarian tissues [47, 51] . In the latter case, the lesions were undetectable in the initial PET scan but showed high uptake in the second PET scan which was preceded by injection of Cosyntropin, which is a synthetic analogue of ACTH.
Polycystic ovaries
Increased prevalence of polycystic ovaries has been shown by Hague et al. [52] . They found 85% (29 of 34) adults, 40% (4 of 10) post-pubertal girls (aged 11-16) and 3% (1 of 31) pre-pubertal and peri-pubertal girls (aged 0.1-13 years) who had CAH had polycystic ovaries on sonography.
Stikkelbroeck et al. however found only 15.4% (2 of 13) CAH patients aged 14.8-24.5 years had sonographic polycystic ovaries, which was similar to the incidence in the general population [44] . It is noteworthy that different hormonal control and imaging criteria used may have led to different results in these studies.
Brain lesions
Increased prevalence (27-45%) of abnormal white matter T2 or FLAIR hyperintensities in the brain, typically at the periventricular region has been reported [53] [54] [55] [56] . An association with temporal lobe structure dysgenesis including amygdala atrophy and hippocampal dysgenesis has also been reported [53, 57] . Evidence on how these are associated with neuropsychological disturbances is scanty and inconclusive. The cause and clinical significance of these have yet to be fully elucidated.
Skeletal system
Advanced skeletal maturation with early epiphyseal plate closure and short resultant final height are common in CAH. Bone age advanced by 2-3 years is common in children with classical CAH. Advanced bone age is more pronounced in boys and in the simple virilizing form [58] . A final height of 1.55 and 1.25 standard deviations below mean were observed for boys and girls respectively in one study [58] . There is also increased prevalence of osteopenia and osteoporosis in CAH patients older than 30 years of age and in postmenopausal women with CAH compared to healthy controls, postulated to be related to gluccocorticoid over-treatment [59] . Bone mineral density in children and young adults are generally normal [59] .
Prostate gland development in female CAH patients
The paraurethral Skene gland in the female is homologous to the prostate gland in the male [60] [61] [62] . Although it has been shown that androgen excess could stimulate prostate gland development in females, the conditions such as timing with respect to embryological development, duration, androgen level and underlying genetic predisposition required for this to happen are still uncertain [63] . To the best of our knowledge, there are to date 11 published articles documenting development of prostatic tissue in female CAH patients with a total of 16 reported cases [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] , making our patient the 17th case. Only one case of adenocarcinoma of the prostate and one case of benign prostatic hypertrophy in female CAH patients have been reported [67, 68] . In the largest study by Paulino Mda et al., 15.6% (5 out of 32) of female patients with classical CAH had MRI evidence of prostate gland development [66] . However in the series by Doherty et al., all 11 adult female CAH patients who underwent pelvic MRI had no evidence of prostate gland development despite 7 of them had marked androgen excess [75] . If the true prevalence is anywhere close to that reported by Paulino Mda et al., then this phenomenon is very much under-reported.
In the study by Paulino Mda et al., all female CAH patients with MRI visible prostate gland development had a prostate specific antigen (PSA) level of >0.1ng/mL [66] . PSA has also been recently found to be a marker for hyperandrogenism in females outside the context of CAH [76] [77] [78] [79] . However, elevated levels could also result from breast fibroadenomas and cysts [80] . Whether the imaging appearance of the Skene/prostate gland in females may also serve as a marker for hyperandrogenism outside the context of CAH may be worth exploring.
Although our patient showed such a sizable prostate gland on CT, it was deemed at most only partly responsible for his urinary symptoms, with the most likely cause being repeated episodes of urinary tract infection related to his lower urinary tract malformation. The extreme case of acute retention of urine due to prostate enlargement in a female CAH patient has only been reported once in the literature [68] .
Treatment and prognosis
The mainstay of treatment for all forms of CAH is corticosteroid replacement. The salt losing form is typically fatal without treatment. Prognosis is generally good with adequate treatment. A significant cause of mortality is inadequate treatment particularly during times of stress such as infection especially in early childhood [81] . Fertility can be achieved with treatment in both female and male. In affected pregnancies, corticosteroid replacement in the mother can prevent ambiguous genitalia in the female fetus. Short final height is unfortunately common in the classical forms despite treatment [58, 59] . Other sources of morbidity may arise from metabolic consequences of under-or over-treatment such as obesity, insulin resistance, hypertension and osteoporosis [59] .
Differential diagnosis
The appearance of the adrenal glands in CAH is indistinguishable from that in ACTH dependent Cushing syndrome, which comprises Cushing's disease (pituitary ACTH producing adenoma) and ectopic ACTH. This is expected as the changes in adrenal morphology are due to the same cause, i.e. chronically increased ACTH levels. Cushing's disease and ectopic ACTH are however clinically evidently different from CAH as they present with hypercortisolism instead. Primary adrenal hyperplasia, typically presenting as Conn's syndrome, is another differential which may have similar adrenal morphology but has distinguishably different biochemical profile. Differentiating between these entities is beyond CT or MRI and has to rely on biochemistry.
As for the solitary adrenal mass in our patient, the large size and intense contrast enhancement raised suspicion for phaeochromocytoma. Although rapid contrast washout of >60% (absolute) at 15 min delayed scan is generally diagnostic of adenomas, phaeochromocytomas are known to overlap with adenomas in this regard. This differential was however considered unlikely given the non-elevated catecholamine levels and normal blood pressure. Malignancy was also a consideration given the large size, pre-contrast attenuation >30HU and lack of intralesional macroscopic fat which if present would suggest myelolipoma which is typically large. But the largely homogenous texture, well defined regular outline and rapid contrast washout were features against malignancy.
As for the presence of a uterus in a phenotypic male, the differentials include true hermaphroditism and other intersex conditions, all of which are extremely rare.
However, when bilateral diffuse adrenal enlargement is combined with presence of a uterus in a phenotypic male, the only unifying diagnosis is CAH in a female patient.
Congenital adrenal hyperplasia (CAH) is a metabolic disease with imaging manifestations in various organ systems. When bilateral diffuse adrenal enlargement is seen in combination with presence of a uterus in a phenotypic male, the only unifying diagnosis is CAH in a female. Do not be surprised if a prostate gland is seen. Omnipaque 300 given at 2mL/second; All images were from portovenous phase scan performed at 75 seconds after contrast injection)
